Telles has anounced that Francisco Espregueira Mendes will be the firm’s new managing partner, replacing Miguel Torres. Mendes will commence a new mandate for the three-year period 2024-2026. He will be supported by a
Tags :Francisco Espregueira Mendes
Telles has advised Beta Capital, a management company for collective investment schemes, on the creation and launch of the Sogrape Ventures venture capital fund. The Sogrape Ventures Fund is designed to invest in disruptive start-ups
Telles has advised the shareholders of BlueClinical on the integration of BlueClinical into Astrum, a pan-European group recently created by Henko Capital Partners, providing high quality CRO (Clinic Research Organisation) services to the pharmaceutical, biotechnology,
Telles has advised the shareholders of BlueClinical on the integration of BlueClinical into Astrum, a pan-European group recently created by Henko Capital Partners, providing high quality CRO (Clinic Research Organisation) services to the pharmaceutical, biotechnology,
Telles has advised Cristalmax and Maxtrends Holding (majority shareholder of Cristalmax) on the investment and participation of Activecap – Capital Partners in the share capital of Cristalmax. The firm advised Cristalmax, a national company specialising in
Telles has advised Proinveste and Casaplus – Sistemas de Energía on the sale of 100% of the share capital and voting rights of Cirelius, a portuguese company in the renewable energy industry, to Arbonia. By
